Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis (2017)
Source: Frontiers in Physiology. Unidade: FM
Subjects: INFLAMAÇÃO, DOENÇAS OCUPACIONAIS, FIBROSE PULMONAR, FÁRMACOS (SISTEMA RESPIRATÓRIO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO, Priscila J. et al. Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis. Frontiers in Physiology, v. 8, p. 15 , 2017Tradução . . Disponível em: http://journal.frontiersin.org/article/10.3389/fphys.2017.00159. Acesso em: 01 nov. 2024.APA
Carneiro, P. J., Clevelario, A. L., Padilha, G. A., Silva, J. D., Kitoko, J. Z., Olsen, P. C., et al. (2017). Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis. Frontiers in Physiology, 8, 15 . doi:10.3389/fphys.2017.00159NLM
Carneiro PJ, Clevelario AL, Padilha GA, Silva JD, Kitoko JZ, Olsen PC, Capelozzi VL, Rocco PRM, Cruz FF. Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis [Internet]. Frontiers in Physiology. 2017 ; 8 15 .[citado 2024 nov. 01 ] Available from: http://journal.frontiersin.org/article/10.3389/fphys.2017.00159Vancouver
Carneiro PJ, Clevelario AL, Padilha GA, Silva JD, Kitoko JZ, Olsen PC, Capelozzi VL, Rocco PRM, Cruz FF. Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis [Internet]. Frontiers in Physiology. 2017 ; 8 15 .[citado 2024 nov. 01 ] Available from: http://journal.frontiersin.org/article/10.3389/fphys.2017.00159
